SAN FRANCISCO, Feb. 8,
2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading
digital platform for U.S. medical professionals, today announced
results for the fiscal 2022 third quarter ended December 31,
2021.
"We had a strong Q3 led by our existing clients as our net
revenue retention rate hit 171%," said Jeff
Tangney, co-founder & CEO at Doximity. "Our telehealth
platform grew to 350,000 active providers and we agreed to acquire
Amion which powers nearly 200,000 physician schedules. It's our
life's work to build the physician cloud – a digital platform to
help physicians save time, so they can provide better care for
patients."
Doximity Acquiring Amion: More information can be found
in the press release at https://investors.doximity.com.
Fiscal 2022 Third Quarter Financial Highlights
All comparisons, unless otherwise noted, are to the three months
ended December 31, 2020.
- Revenue: Revenue of $97.9
million, versus $58.7 million,
an increase of 67% year-over-year.
- Net income and non-GAAP net income: Net income of
$55.6 million, versus $17.2 million, representing a 57% margin.
Non-GAAP net income of $63.6 million,
versus $19.5 million, representing a
65% margin.
- Adjusted EBITDA: Adjusted EBITDA of $47.0 million, versus $21.5 million, an increase of 119%
year-over-year, representing adjusted EBITDA margins of 48%, versus
37%.
- Net income per share and non-GAAP net income per share:
Diluted net income per share was $0.26, versus $0.05, while non-GAAP diluted net income per
share was $0.29, versus $0.07.
- Operating cash flow and free cash flow: Operating cash
flow of $27.3 million, versus
$24.0 million, and free cash flow of
$25.6 million, versus $22.9 million.
Financial Outlook
Doximity is providing guidance for its fiscal fourth quarter
ending March 31, 2022 as follows:
- Revenue between $89.0 million and
$90.0 million.
- Adjusted EBITDA between $34.0
million and $35.0
million.
Doximity is updating guidance for its fiscal year ending
March 31, 2022 as follows:
- Revenue between $338.9 million
and $339.9 million.
- Adjusted EBITDA between $144.9
million and $145.9
million.
Doximity is providing preliminary guidance for its fiscal year
ending March 31, 2023 as follows:
- Revenue growth of about 33% (excluding the Amion acquisition)
to approximately $450 million.
- Adjusted EBITDA margin of 40% or greater (excluding the Amion
acquisition).
Conference Call Information
Doximity will host a webcast today at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to discuss these
financial results. To listen to a live audio webcast, please visit
the Company's Investor Relations page at
https://investors.doximity.com. The archived webcast will be
available on the Company's Investor Relations page shortly after
the call.
About Doximity
Founded in 2010, Doximity is the leading digital platform for
medical professionals. The company's network members include over
80% of U.S. physicians across all specialties and practice areas.
Doximity provides its verified clinical membership with digital
tools built for medicine, enabling them to collaborate with
colleagues, stay up to date with the latest medical news and
research, manage their careers, and conduct virtual patient visits.
Doximity's mission is to help doctors be more productive so they
can provide better care for their patients. For more information,
please visit www.doximity.com.
Forward-Looking Statements
Statements we make in this press release may include
statements which are not historical facts and are considered
forward-looking within the meaning of Section 27A of the Securities
Act and Section 21E of the Securities Exchange Act, which are
usually identified by the use of words such as "anticipates,"
"believes," "estimates," "expects," "intends," "may," "plans,"
"projects," "seeks," "should," "will," and variations of such words
or similar expressions. We intend these forward-looking statements
to be covered by the safe harbor provisions for forward-looking
statements contained in Section 27A of the Securities Act and
Section 21E of the Securities Exchange Act and are making this
statement for purposes of complying with those safe harbor
provisions. These forward-looking statements reflect our current
views about our plans, intentions, expectations, strategies and
prospects, which are based on the information currently available
to us and on assumptions we have made. Although we believe
that our plans, intentions, expectations, strategies and prospects
as reflected in or suggested by those forward-looking statements
are reasonable, we can give no assurance that the plans,
intentions, expectations, or strategies will be attained or
achieved. Furthermore, actual results may differ materially
from those described in the forward-looking statements and will be
affected by a variety of risks and factors including (i) the impact
of the COVID-19 pandemic (including the impact to our industry or
on our customers' industries, impact on general economic
conditions, and government responses, restrictions, and actions
related to the pandemic); (ii) our ability to retain existing
members or add new members to our platform and maintain or grow
their engagement with our platform; (iii) our ability to attract
new customers or retain existing customers; (iv) the impact of our
prioritization of our members' interests; (v) breaches in our
security measures or unauthorized access to members' data; (vi) our
ability to maintain or manage our growth, and other risks and
factors that are beyond our control including, without limitation,
those set forth in the section entitled "Risk Factors" in the
prospectus for our recent offering of shares of Class A common
stock shares that was filed with the SEC on June 25, 2021, and in our Quarterly Report on
Form 10-Q for the quarterly period ended September 30, 2021,
as such risk factors may be updated from time to time in our
periodic filings with the SEC. Additional information will be
provided in our Quarterly Report on Form 10-Q for the
quarterly period ended December 31, 2021. Moreover, we operate
in a very competitive and rapidly changing environment. New risks
and uncertainties emerge from time to time, and it is not possible
for us to predict all risks and uncertainties that could cause
actual results to differ materially from those contained in our
forward-looking statements. The forward-looking statements made in
this press release relate only to management's beliefs and
assumptions as of this date. We assume no obligation to update
publicly any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Investor Relations Contact:
Perry Gold
ir@doximity.com
Media Contact:
pr@doximity.com
DOXIMITY,
INC.
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(in
thousands)
|
(unaudited)
|
|
|
December 31,
2021
|
|
March 31,
2021
|
Assets
|
|
|
|
Current
assets:
|
|
|
|
Cash and cash
equivalents
|
$
85,079
|
|
$
66,393
|
Marketable
securities
|
680,499
|
|
76,141
|
Accounts receivable,
net
|
69,823
|
|
50,319
|
Prepaid expenses and
other current assets
|
17,917
|
|
10,692
|
Deferred contract
costs, current
|
5,060
|
|
5,856
|
Total current
assets
|
858,378
|
|
209,401
|
Property and
equipment, net
|
8,221
|
|
7,598
|
Deferred income tax
assets
|
35,431
|
|
2,112
|
Operating lease
right-of-use assets
|
1,589
|
|
1,339
|
Intangible assets,
net
|
8,802
|
|
9,596
|
Goodwill
|
18,915
|
|
18,915
|
Other
assets
|
836
|
|
2,758
|
Total
assets
|
$
932,172
|
|
$
251,719
|
Liabilities,
Redeemable Convertible Preferred Stock and Stockholders'
Equity
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$
1,230
|
|
$
1,515
|
Accrued expenses and
other current liabilities
|
23,980
|
|
16,285
|
Deferred revenue,
current
|
65,576
|
|
83,272
|
Operating lease
liabilities, current
|
927
|
|
970
|
Total current
liabilities
|
91,713
|
|
102,042
|
Deferred revenue,
non-current
|
38
|
|
220
|
Operating lease
liabilities, non-current
|
668
|
|
284
|
Other liabilities,
non-current
|
905
|
|
972
|
Total
liabilities
|
93,324
|
|
103,518
|
|
|
|
|
Redeemable
Convertible Preferred Stock
|
|
|
|
Redeemable
convertible preferred stock
|
—
|
|
81,458
|
Stockholders'
Equity
|
|
|
|
Preferred
stock
|
—
|
|
—
|
Common
stock
|
190
|
|
83
|
Additional paid-in
capital
|
688,290
|
|
30,357
|
Accumulated other
comprehensive loss
|
(4,013)
|
|
(21)
|
Retained
earnings
|
154,381
|
|
36,324
|
Total stockholders'
equity
|
838,848
|
|
66,743
|
Total liabilities,
redeemable convertible preferred stock, and stockholders'
equity
|
$
932,172
|
|
$
251,719
|
DOXIMITY,
INC.
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
(in thousands,
except per share data)
|
(unaudited)
|
|
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Revenue
|
$
97,876
|
|
$
58,709
|
|
$
249,895
|
|
$
140,210
|
Cost of
revenue(1)
|
11,085
|
|
7,872
|
|
28,022
|
|
23,203
|
Gross
profit
|
86,791
|
|
50,837
|
|
221,873
|
|
117,007
|
Operating
expenses(1):
|
|
|
|
|
|
|
|
Research and
development
|
16,225
|
|
11,406
|
|
44,926
|
|
31,315
|
Sales and
marketing
|
25,698
|
|
17,017
|
|
66,230
|
|
44,447
|
General and
administrative
|
9,079
|
|
4,478
|
|
25,102
|
|
10,789
|
Total operating
expenses
|
51,002
|
|
32,901
|
|
136,258
|
|
86,551
|
Income from
operations
|
35,789
|
|
17,936
|
|
85,615
|
|
30,456
|
Other income,
net
|
20
|
|
4,601
|
|
485
|
|
4,428
|
Income before income
taxes
|
35,809
|
|
22,537
|
|
86,100
|
|
34,884
|
Provision for
(benefit from) income taxes
|
(19,838)
|
|
5,306
|
|
(31,957)
|
|
6,157
|
Net income
|
$
55,647
|
|
$
17,231
|
|
$
118,057
|
|
$
28,727
|
Undistributed
earnings attributable to participating securities
|
—
|
|
(11,831)
|
|
(21,866)
|
|
(17,907)
|
Net income
attributable to Class A and Class B common stockholders, basic and
diluted
|
$
55,647
|
|
$
5,400
|
|
$
96,191
|
|
$
10,820
|
Net income per share
attributable to Class A and Class B common stockholders:
|
|
|
|
|
|
|
|
Basic
|
$
0.30
|
|
$
0.07
|
|
$
0.62
|
|
$
0.15
|
Diluted
|
$
0.26
|
|
$
0.05
|
|
$
0.53
|
|
$
0.12
|
Weighted-average
shares used in computing net income per share attributable to Class
A and Class B common stockholders:
|
|
|
|
|
|
|
|
Basic
|
188,372
|
|
77,766
|
|
154,289
|
|
72,590
|
Diluted
|
216,396
|
|
99,923
|
|
182,905
|
|
92,286
|
|
(1) Costs and
expenses include share-based compensation expenses as
follows:
|
|
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Cost of
revenue
|
$
1,912
|
|
$
179
|
|
$
2,973
|
|
$
368
|
Research and
development
|
2,035
|
|
634
|
|
4,864
|
|
1,179
|
Sales and
marketing
|
2,681
|
|
633
|
|
5,575
|
|
1,304
|
General and
administrative
|
3,206
|
|
774
|
|
8,221
|
|
1,531
|
Total stock-based
compensation expense
|
$
9,834
|
|
$
2,220
|
|
$
21,633
|
|
$
4,382
|
DOXIMITY,
INC.
|
CONDENSED
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(in
thousands)
|
(unaudited)
|
|
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
Cash flows from
operating activities
|
|
|
|
|
|
|
|
Net income
|
$
55,647
|
|
$
17,231
|
|
$
118,057
|
|
$
28,727
|
Adjustments to
reconcile net income to net cash provided by operating
activities
|
|
|
|
|
|
|
|
Depreciation and
amortization
|
1,361
|
|
1,015
|
|
3,672
|
|
2,711
|
Deferred income
taxes
|
(31,972)
|
|
3,450
|
|
(31,972)
|
|
4,073
|
Stock-based
compensation, net of amounts capitalized
|
9,834
|
|
2,220
|
|
21,633
|
|
4,382
|
Other
|
642
|
|
(287)
|
|
570
|
|
(182)
|
Non-cash lease
expense
|
288
|
|
718
|
|
857
|
|
2,012
|
Bad debt expense
(recovery)
|
(120)
|
|
(47)
|
|
75
|
|
(43)
|
Amortization of premium
on marketable securities, net
|
1,302
|
|
44
|
|
2,863
|
|
58
|
Gain on sale of
business
|
—
|
|
(4,698)
|
|
—
|
|
(4,698)
|
Amortization of
deferred contract costs
|
1,710
|
|
1,557
|
|
7,366
|
|
4,697
|
Changes in operating
assets and liabilities, net of effect of acquisition:
|
|
|
|
|
|
|
|
Accounts
receivable
|
(14,021)
|
|
403
|
|
(19,579)
|
|
(14,487)
|
Prepaid expenses and
other assets
|
10,722
|
|
(596)
|
|
(7,003)
|
|
167
|
Deferred contract
costs
|
(3,697)
|
|
(3,215)
|
|
(6,672)
|
|
(5,970)
|
Accounts
payable
|
453
|
|
(658)
|
|
162
|
|
(933)
|
Accrued expenses and
other current liabilities
|
8,417
|
|
6,155
|
|
7,998
|
|
5,512
|
Deferred
revenue
|
(13,111)
|
|
830
|
|
(17,538)
|
|
19,373
|
Operating lease
liabilities
|
(173)
|
|
(730)
|
|
(811)
|
|
(2,040)
|
Other
liabilities
|
2
|
|
569
|
|
(67)
|
|
2,063
|
Net cash provided
by operating activities
|
27,284
|
|
23,961
|
|
79,611
|
|
45,422
|
Cash flows from
investing activities
|
|
|
|
|
|
|
|
Purchases of property
and equipment
|
(611)
|
|
(6)
|
|
(852)
|
|
(98)
|
Capitalized
internal-use software
|
(1,065)
|
|
(1,069)
|
|
(2,736)
|
|
(3,599)
|
Purchases of
marketable securities
|
(115,772)
|
|
(34,399)
|
|
(1,271,915)
|
|
(34,399)
|
Maturities of
marketable securities
|
6,066
|
|
4,000
|
|
41,617
|
|
38,000
|
Sales of marketable
securities
|
85,862
|
|
—
|
|
616,938
|
|
—
|
Cash paid for
acquisition, net of cash acquired
|
—
|
|
(48)
|
|
—
|
|
(31,682)
|
Other
|
—
|
|
25
|
|
—
|
|
—
|
Proceeds from sale of
business
|
—
|
|
4,230
|
|
—
|
|
4,230
|
Net cash used in
investing activities
|
(25,520)
|
|
(27,267)
|
|
(616,948)
|
|
(27,548)
|
Cash flows from
financing activities
|
|
|
|
|
|
|
|
Proceeds from
issuance of common stock upon initial public offering after
deducting underwriting discounts and commissions
|
—
|
|
—
|
|
553,905
|
|
—
|
Payments of deferred
offering costs
|
—
|
|
(381)
|
|
(3,982)
|
|
(381)
|
Proceeds from
issuance of common stock upon exercise of stock options
|
4,174
|
|
3,075
|
|
9,234
|
|
4,422
|
Taxes paid related to
net share settlement of equity awards
|
(380)
|
|
—
|
|
(436)
|
|
—
|
Repurchase of common
stock
|
—
|
|
(370)
|
|
(2,698)
|
|
(370)
|
Net cash provided
by financing activities
|
3,794
|
|
2,324
|
|
556,023
|
|
3,671
|
Net increase
(decrease) in cash and cash equivalents
|
5,558
|
|
(982)
|
|
18,686
|
|
21,545
|
Cash and cash
equivalents, beginning of period
|
79,521
|
|
70,957
|
|
66,393
|
|
48,430
|
Cash and cash
equivalents, end of period
|
$
85,079
|
|
$
69,975
|
|
$
85,079
|
|
$
69,975
|
Non-GAAP Financial Measures
To supplement our condensed consolidated financial statements,
which are prepared and presented in accordance with accounting
principles generally accepted in the
United States ("GAAP"), the Company uses the following
non-GAAP measures of financial performance:
- Non-GAAP gross profit, non-GAAP gross margin, non-GAAP
operating income, non-GAAP net income, non-GAAP net income margin,
and non-GAAP basic and diluted net income per common share: We
exclude the effect of stock-based compensation expense,
amortization of acquired intangible assets, and expenses associated
with acquisitions from non-GAAP gross profit, non-GAAP gross margin
and non-GAAP operating income. Non-GAAP net income and non-GAAP net
income margin are further adjusted for estimated income tax on such
adjustments. We calculate income taxes on the adjustments by
applying an estimated annual effective tax rate to the adjustments.
Non-GAAP basic and diluted net income per common share is non-GAAP
net income attributable to common stockholders divided by the
weighted average number of shares. For both basic and diluted
non-GAAP net income per share, the weighted average shares we use
in computing non-GAAP net income per share is equal to our GAAP
weighted average shares. Non-GAAP gross margin represents non-GAAP
gross profit as a percentage of revenue and non-GAAP net income
margin represents non-GAAP net income as a percentage of
revenue.
- Adjusted EBITDA and adjusted EBITDA margin: We define
adjusted EBITDA as net income before interest, income taxes,
depreciation, and amortization, and as further adjusted for
acquisition and other related expenses, stock-based compensation
expense, and other income, net. Adjusted EBITDA margin represents
adjusted EBITDA as a percentage of revenue.
- Free cash flow: We calculate free cash flow as cash flow
from operating activities less purchases of property and equipment
and capitalized internal-use software development cost.
We use these non-GAAP financial measures internally for
financial and operational decision-making purposes and as a means
to evaluate period-to-period comparisons. Non-GAAP financial
measures are not meant to be considered in isolation or as a
substitute for comparable GAAP financial measures and should be
read only in conjunction with our condensed consolidated financial
statements prepared in accordance with GAAP. Our presentation of
non-GAAP financial measures may not be comparable to similar
measures used by other companies. We encourage investors to
carefully consider our results under GAAP, as well as our
supplemental non-GAAP information and the reconciliation between
these presentations, to more fully understand our business. Please
see the tables included at the end of this release for the
reconciliation of GAAP to non-GAAP results.
Key Business Metrics
- Net revenue retention rate: We calculate net revenue
retention rate by taking the trailing 12-month ("TTM")
subscription-based revenue from our customers that had revenue in
the prior TTM period and dividing that by the total
subscription-based revenue for the prior TTM period. Our net
revenue retention rate compares our subscription revenue from the
same set of customers across comparable periods, and reflects
customer renewals, expansion, contraction, and churn.
- Customers with trailing 12-month subscription revenue
greater than $100,000: We
calculate the number of customers with TTM product revenue greater
than $100,000 by counting the number
of customers that contributed more than $100,000 in subscription revenue in the TTM
period. The number of customers with TTM subscription-based revenue
of at least $100,000 is a key
indicator of the scale of our business. Our customer count is
subject to adjustments for acquisitions, consolidations, spin-offs,
and other market activity.
Reconciliation of GAAP to Non-GAAP Financial
Measures
The following tables reconcile the specific items excluded from
GAAP metrics in the calculation of non-GAAP metrics for the periods
shown below:
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
(unaudited)
|
|
(in
thousands)
|
Net income
|
$
55,647
|
|
$
17,231
|
|
$ 118,057
|
|
$
28,727
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Acquisition and other
related expenses
|
—
|
|
326
|
|
—
|
|
470
|
Stock-based
compensation
|
9,834
|
|
2,220
|
|
21,633
|
|
4,382
|
Depreciation and
amortization
|
1,361
|
|
1,015
|
|
3,672
|
|
2,711
|
Provision for (benefit
from) income taxes
|
(19,838)
|
|
5,306
|
|
(31,957)
|
|
6,157
|
Other income,
net
|
(20)
|
|
(4,601)
|
|
(485)
|
|
(4,428)
|
Adjusted
EBITDA
|
$
46,984
|
|
$
21,497
|
|
$ 110,920
|
|
$
38,019
|
|
|
|
|
|
|
|
|
Revenue
|
$
97,876
|
|
$
58,709
|
|
$ 249,895
|
|
$ 140,210
|
Net income
margin
|
57
%
|
|
29
%
|
|
47
%
|
|
20
%
|
Adjusted EBITDA
margin
|
48
%
|
|
37
%
|
|
44
%
|
|
27
%
|
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
(unaudited)
|
|
(in
thousands)
|
Net cash provided by
operating activities
|
$
27,284
|
|
$
23,961
|
|
$
79,611
|
|
$
45,422
|
Purchases of property
and equipment
|
(611)
|
|
(6)
|
|
(852)
|
|
(98)
|
Capitalized
internal-use software
|
(1,065)
|
|
(1,069)
|
|
(2,736)
|
|
(3,599)
|
Free cash
flow
|
$
25,608
|
|
$
22,886
|
|
$
76,023
|
|
$
41,725
|
Other cash flow
components:
|
|
|
|
|
|
|
|
Net cash used in
investing activities
|
$
(25,520)
|
|
$
(27,267)
|
|
$
(616,948)
|
|
$
(27,548)
|
Net cash provided by
financing activities
|
$
3,794
|
|
$
2,324
|
|
$
556,023
|
|
$
3,671
|
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
(unaudited)
|
|
(in thousands,
except percentages)
|
GAAP cost of
revenue
|
$
11,085
|
|
$
7,872
|
|
$
28,022
|
|
$
23,203
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Stock-based
compensation
|
(1,912)
|
|
(179)
|
|
(2,973)
|
|
(368)
|
Non-GAAP cost of
revenue
|
$
9,173
|
|
$
7,693
|
|
$
25,049
|
|
$
22,835
|
|
|
|
|
|
|
|
|
GAAP gross
profit
|
$
86,791
|
|
$
50,837
|
|
$ 221,873
|
|
$ 117,007
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Stock-based
compensation
|
1,912
|
|
179
|
|
2,973
|
|
368
|
Non-GAAP gross
profit
|
$
88,703
|
|
$
51,016
|
|
$ 224,846
|
|
$ 117,375
|
|
|
|
|
|
|
|
|
GAAP gross
margin
|
89
%
|
|
87
%
|
|
89
%
|
|
83
%
|
Non-GAAP gross
margin
|
91
%
|
|
87
%
|
|
90
%
|
|
84
%
|
|
|
|
|
|
|
|
|
GAAP research and
development expense
|
$
16,225
|
|
$
11,406
|
|
$
44,926
|
|
$
31,315
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Stock-based
compensation
|
(2,035)
|
|
(634)
|
|
(4,864)
|
|
(1,179)
|
Non-GAAP research and
development expense
|
$
14,190
|
|
$
10,772
|
|
$
40,062
|
|
$
30,136
|
|
|
|
|
|
|
|
|
GAAP sales and
marketing expense
|
$
25,698
|
|
$
17,017
|
|
$
66,230
|
|
$
44,447
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Stock-based
compensation
|
(2,681)
|
|
(633)
|
|
(5,575)
|
|
(1,304)
|
Amortization of
acquired intangibles
|
(265)
|
|
(303)
|
|
(795)
|
|
(817)
|
Non-GAAP sales and
marketing expense
|
$
22,752
|
|
$
16,081
|
|
$
59,860
|
|
$
42,326
|
|
|
|
|
|
|
|
|
GAAP general and
administrative expense
|
$
9,079
|
|
$
4,478
|
|
$
25,102
|
|
$
10,789
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Acquisition and other
related expenses
|
—
|
|
(326)
|
|
—
|
|
(470)
|
Stock-based
compensation
|
(3,206)
|
|
(774)
|
|
(8,221)
|
|
(1,531)
|
Non-GAAP general and
administrative expense
|
$
5,873
|
|
$
3,378
|
|
$
16,881
|
|
$
8,788
|
|
|
|
|
|
|
|
|
GAAP operating
expense
|
$
51,002
|
|
$
32,901
|
|
$ 136,258
|
|
$
86,551
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Acquisition and other
related expenses
|
—
|
|
(326)
|
|
—
|
|
(470)
|
Stock-based
compensation
|
(7,922)
|
|
(2,041)
|
|
(18,660)
|
|
(4,014)
|
Amortization of
acquired intangibles
|
(265)
|
|
(303)
|
|
(795)
|
|
(817)
|
Non-GAAP operating
expense
|
$
42,815
|
|
$
30,231
|
|
$ 116,803
|
|
$
81,250
|
|
|
|
|
|
|
|
|
GAAP operating
income
|
$
35,789
|
|
$
17,936
|
|
$
85,615
|
|
$
30,456
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Acquisition and other
related expenses
|
—
|
|
326
|
|
—
|
|
470
|
Stock-based
compensation
|
9,834
|
|
2,220
|
|
21,633
|
|
4,382
|
Amortization of
acquired intangibles
|
265
|
|
303
|
|
795
|
|
817
|
Non-GAAP operating
income
|
$
45,888
|
|
$
20,785
|
|
$ 108,043
|
|
$
36,125
|
|
Three Months
Ended
December 31,
|
|
Nine Months
Ended
December 31,
|
|
2021
|
|
2020
|
|
2021
|
|
2020
|
|
(unaudited)
|
|
(in thousands,
except per share data and percentages)
|
GAAP net
income
|
$
55,647
|
|
$
17,231
|
|
$
118,057
|
|
$
28,727
|
Adjusted to exclude
the following:
|
|
|
|
|
|
|
|
Acquisition and other
related expenses
|
—
|
|
326
|
|
—
|
|
470
|
Stock-based
compensation
|
9,834
|
|
2,220
|
|
21,633
|
|
4,382
|
Amortization of
acquired intangibles
|
265
|
|
303
|
|
795
|
|
817
|
Income tax effect of
non-GAAP adjustments (1)
|
(2,121)
|
|
(598)
|
|
(4,710)
|
|
(1,190)
|
Non-GAAP net
income
|
$
63,625
|
|
$
19,482
|
|
$
135,775
|
|
$
33,206
|
Non-GAAP net income
margin
|
65
%
|
|
33
%
|
|
54
%
|
|
24
%
|
|
|
|
|
|
|
|
|
GAAP undistributed
earnings attributable to participating securities
|
$
—
|
|
$ (11,831)
|
|
$ (21,866)
|
|
$ (17,907)
|
Impact on
undistributed earnings attributable to participating securities due
to non-GAAP adjustments
|
—
|
|
(1,114)
|
|
(2,436)
|
|
(2,295)
|
Non-GAAP
undistributed earnings attributable to participating
securities
|
$
—
|
|
$ (12,945)
|
|
$ (24,302)
|
|
$ (20,202)
|
|
|
|
|
|
|
|
|
Non-GAAP net
income
|
$
63,625
|
|
$
19,482
|
|
$
135,775
|
|
$
33,206
|
Non-GAAP
undistributed earnings attributable to participating
securities
|
—
|
|
(12,945)
|
|
(24,302)
|
|
(20,202)
|
Non-GAAP net income
attributable to Class A and Class B stockholders, basic and
diluted
|
$
63,625
|
|
$
6,537
|
|
$
111,473
|
|
$
13,004
|
|
|
|
|
|
|
|
|
Weighted-average
shares used in computing net income per share attributable to Class
A and Class B common stockholders:
|
|
|
|
|
|
|
|
Basic
|
188,372
|
|
77,766
|
|
154,289
|
|
72,590
|
Diluted
|
216,396
|
|
99,923
|
|
182,905
|
|
92,286
|
|
|
|
|
|
|
|
|
Non-GAAP net income
per share attributable to Class A and Class B
stockholders:
|
|
|
|
|
|
|
|
Basic
|
$
0.34
|
|
$
0.08
|
|
$
0.72
|
|
$
0.18
|
Diluted
|
$
0.29
|
|
$
0.07
|
|
$
0.61
|
|
$
0.14
|
|
(1) For
the three and nine months ended December 31, 2021 and 2020,
management used an estimated annual effective non-GAAP tax rate of
21.0%.
|
View original
content:https://www.prnewswire.com/news-releases/doximity-announces-fiscal-2022-third-quarter-financial-results-301477814.html
SOURCE Doximity, Inc.